Literature DB >> 3116907

The cost of antiglaucoma medications.

K S Kooner1, T J Zimmerman.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3116907

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN： 0003-4886


× No keyword cloud information.
  6 in total

Review 1.  The economic implications of glaucoma: a literature review.

Authors:  Jordana K Schmier; Michael T Halpern; Mechelle L Jones
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  A diabetes control program in a public health care setting.

Authors:  S B Baker; C Vallbona; V Pavlik; C E Fasser; M Armbruster; R McCray; R L Baker
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

3.  Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries.

Authors:  Jean-Francois Rouland; Claude Le Pen; Carlos Gouveia Pinto; Patrizia Berto; Gilles Berdeaux
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.

Authors:  Renato De Natale; Antoine Lafuma; Gilles Berdeaux
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

5.  Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database.

Authors:  Antoine Lafuma; John F Salmon; Julien Robert; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2011-03-14

6.  Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database.

Authors:  Philippe Denis; Antoine Lafuma; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2008-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.